Palabras clave
Control Continuo de la glucosa
Diabetes Mellitus Tipo 2
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: Analizar el impacto del uso de dispositivos de monitorización continua de glucosa sobre el control glucémico y la calidad de vida en personas con diabetes tipo 2. Métodos: Se realizó una revisión integradora utilizando la plataforma de bases de datos Pubmed con el fin de localizar fuentes relevantes. La búsqueda se realizó utilizando los descriptores "Blood Glucose Self-Monitoring", "Continuous Glucose Monitoring", "Diabetes Mellitus, Type 2" y "Diabetes Mellitus, Type 1", en asociación con los operadores booleanos "AND","OR" y "NOT", para buscar artículos, dando como resultado 853 artículos iniciales. Dentro de estos números, debido a los criterios de inclusión y exclusión, sólo 23 fueron seleccionados. Resultados: Los estudios señalan una estrecha relación entre la monitorización continua de glucosa y la reducción del riesgo y frecuencia de episodios hipoglucémicos e hiperglucémicos, así como la reducción y/o mantenimiento de la HbA1c y la prevención del deterioro glucémico en pacientes con DM2. Consideraciones finales: El uso de la monitorización continua de glucosa en pacientes con DM2 ayuda a regular la glucemia, minimiza la incidencia de episodios hiperglucémicos e hipoglucémicos y optimiza el estilo de vida del paciente, pero no parece reducir el malestar general causado por la diabetes.
Referencias
BREYTON AE, et al. CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review. Front Endocrinol (Lausanne), 2021; 12: 666008.
CHEN M, et al. Flash Glucose Monitoring Improves Glucose Control in People with Type 2 Diabetes Mellitus Receiving Anti-diabetic Drug Medication. Exp Clin Endocrinol Diabetes, 2021; 129(12): 857-863.
FURLER J, et al. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practive (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controllled trial. Lancet Diabetes Endocrinal, 2020; 8(1): 17-26.
GUNAWARDENA KC, et al. The Influence of the Smart Glucose Manager Mobile Application on Diabetes Management. J Diabetes Sci Technol, 2019; 13(1): 75-81.
IDA S, et al. Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Res, 2019: 4684815.
JACKSON MA, et al. Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring. Diabetes Technology & Therapeutics, 2021; 23: 27-34.
JANAPALA RN, et al. Continuous Glucose Monitoring Versus Self monitoring of Blood Glucose in Type 2 Diabetes Mellitus: A Systematic Review with Meta-analysis. Cureus, 2019; 11(9): e5634.
KARTER AJ, et al. Continuous Glucose Monitor Use Prevents Glycemic Deterioration in Insulin-Treated Patients with Type 2 Diabetes. Diabetes Technol Ther, 2022; 24(5): 332-337.
KEBEDE MM, et al. Effectiveness of Digital Interventions for Improving Glycemic Control in Persons with Poorly Controlled Type 2 diabetes: A Systematic Review, Meta-analysis, and Meta-regression Analysis. Diabetes Technology & Therapeutics, 2018; 20(11): 767-782.
KIEU A, et al. The Benefits of Utilizing Continuous Glucose Monitoring of Diabetes Mellitus in Primary Care: A Systematic Review. J Diabetes Sci Technol, 2023; 17(3): 762-774.
LEE SK, et al. Effect of Diabetes Education Through Pattern Management on Self-Care and Self-Efficacy in Patients with Type 2 Diabetes. Int J Environ Res Public Health, 2019; 16(18): 3323.
MANFREDO J, et al. Short-term use of CGM in youth onset type 2 diabetes is associated with behavioral modifications. Frontiers, 2023; 14: e1182260.
MILLER E, et al. What Role Might There Be for Continuous Glucose Monitoring in the Assessment of Diabetes Risk?. Diabetes Technol Ther, 2023; 25(S3): S14-S20.
MONTERO AR, et al. Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care. BMC Endocrine Disorders, 2021; 21(1): 1-8.
OGAWA W, et al. Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan. J Diabetes Investig, 2021; 12(1): 82-90.
OSER TK, et al. Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efcacy and Economic Impacts. Current Diabetes Reports, 2021; 21: 1-16.
PAGLIALUNGA S, et al. Tracking the Sugar Rush: Incorporating Continuous Glucose Monitoring Into Multisite Early Clinical Research With Type 2 Diabetes Subjects. Clinical Pharmacology in Drug Development, 2018; 7(7): 676-683.
RIVERA-ÁVILA DC, et al. The effects of professional continuous glucose monitoring as an adjuvante educational tool for improving glycemic control in patients with type 2 diabetes. BMC Endocrine Disorders, 2021; 21: 1-9.
WANDA E, el al. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care, 2020; 8(1): e001115.
WRIGHT EE, SUBRAMANIAN S. Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment. Diabetes Technology & Therapeutics, 2021; 23: 12-18.
XU Y, et al. Evaluating the impact of self-monitoring of blood glucose frequencies on glucose control in patients with type 2 diabetes who do not use insulin: A systematic review and meta-analysis. Int J Clin Pract, 2019; 73(7): e13357.
YARON M, et al. Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes. Diabetes Care, 2019; 42(7): 1178-1184.
ZHENG M, et al. Barriers and facilitators of diabetes management by continuous glucose monitoring systems among adults with type 2 diabetes: a protocol of qualitative systematic review. BMJ Open, 2021; 11(10): e046050.
ZHENG M, et al. Comparing effects of continuous glucose monitoring systems (CGMs) and self-monitoring of blood glucose (SMBG) amongst adults with type 2 diabetes mellitus: a systematic review protocol. Syst Ver, 2020; 9(1): 1-6.